Carmen Infante-Domínguez, Sonsoles Salto-Alejandre, Rocío Álvarez-Marín, Nuria Sabé, Antonio Ramos-Martínez, Asunción Moreno, Kamilla Ferreira de Moraes, Zaira R Palacios-Baena, Patricia Muñoz, Mario Fernández-Ruiz, Marino Blanes, Carmen Fariñas, Elisa Vidal, Esperanza Merino de Lucas, Márcia Halpern, Román Hernández-Gallego, Matteo Bassetti, Alessandra Mularoni, Alex Gutiérrez-Dalmau, Matteo Rinaldi, Silvia Jiménez-Jorge, Marta Bodro, Luis Fernando Aranha-Camargo, Maricela Valerio, Javier Sánchez-Céspedes, Belén Gutiérrez-Gutiérrez, Maddalena Giannella, Jesús Rodríguez-Baño, Jerónimo Pachón, Elisa Cordero
{"title":"接种和未接种实体器官移植受体的COVID-19临床表型:一项多中心验证研究","authors":"Carmen Infante-Domínguez, Sonsoles Salto-Alejandre, Rocío Álvarez-Marín, Nuria Sabé, Antonio Ramos-Martínez, Asunción Moreno, Kamilla Ferreira de Moraes, Zaira R Palacios-Baena, Patricia Muñoz, Mario Fernández-Ruiz, Marino Blanes, Carmen Fariñas, Elisa Vidal, Esperanza Merino de Lucas, Márcia Halpern, Román Hernández-Gallego, Matteo Bassetti, Alessandra Mularoni, Alex Gutiérrez-Dalmau, Matteo Rinaldi, Silvia Jiménez-Jorge, Marta Bodro, Luis Fernando Aranha-Camargo, Maricela Valerio, Javier Sánchez-Céspedes, Belén Gutiérrez-Gutiérrez, Maddalena Giannella, Jesús Rodríguez-Baño, Jerónimo Pachón, Elisa Cordero","doi":"10.1038/s41598-024-81099-2","DOIUrl":null,"url":null,"abstract":"<p><p>Clinical phenotypes of COVID-19, associated with mortality risk, have been identified in the general population. The present study assesses their applicability in solid organ transplant recipients (SOTR) hospital-admitted by COVID-19. In a cohort of 488 SOTR, nonvaccinated (n = 394) and vaccinated (n = 94) against SARS-CoV-2, we evaluated 16 demographic, clinical, analytical, and radiological variables to identify the clinical phenotypes A, B, and C. The median age was 61.0 (51-69) years, 330 (67.6%) and 158 (32.4%) were men and women, respectively, 415 (85%) had pneumonia, and 161 (33%) had SpO<sub>2</sub> < 95% at admission. All-cause mortality occurred in 105 (21.5%) cases. It was higher in nonvaccinated versus vaccinated SOTR (23.4% vs 13.8%, P = 0.04). Patients in the entire cohort were classified into phenotypes A (n = 149, 30.5%), B (n = 187, 38.3%), and C (n = 152, 31.1%), with mortality rates of 8.7%, 16.6%, and 40.1%, respectively, which were similar to those of nonvaccinated SOTR (9.5%, 16.7%, and 52.0%) and lower in vaccinated SOTR (4.4%, 15.8%, and 17.3%, respectively), with difference between nonvaccinated and vaccinated in the phenotype C (P < 0.001). In conclusion, COVID-19 clinical phenotypes are useful in SOTR, and all-cause mortality decreases in vaccinated patients.</p>","PeriodicalId":21811,"journal":{"name":"Scientific Reports","volume":"14 1","pages":"30021"},"PeriodicalIF":3.9000,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11612230/pdf/","citationCount":"0","resultStr":"{\"title\":\"COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study.\",\"authors\":\"Carmen Infante-Domínguez, Sonsoles Salto-Alejandre, Rocío Álvarez-Marín, Nuria Sabé, Antonio Ramos-Martínez, Asunción Moreno, Kamilla Ferreira de Moraes, Zaira R Palacios-Baena, Patricia Muñoz, Mario Fernández-Ruiz, Marino Blanes, Carmen Fariñas, Elisa Vidal, Esperanza Merino de Lucas, Márcia Halpern, Román Hernández-Gallego, Matteo Bassetti, Alessandra Mularoni, Alex Gutiérrez-Dalmau, Matteo Rinaldi, Silvia Jiménez-Jorge, Marta Bodro, Luis Fernando Aranha-Camargo, Maricela Valerio, Javier Sánchez-Céspedes, Belén Gutiérrez-Gutiérrez, Maddalena Giannella, Jesús Rodríguez-Baño, Jerónimo Pachón, Elisa Cordero\",\"doi\":\"10.1038/s41598-024-81099-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Clinical phenotypes of COVID-19, associated with mortality risk, have been identified in the general population. The present study assesses their applicability in solid organ transplant recipients (SOTR) hospital-admitted by COVID-19. In a cohort of 488 SOTR, nonvaccinated (n = 394) and vaccinated (n = 94) against SARS-CoV-2, we evaluated 16 demographic, clinical, analytical, and radiological variables to identify the clinical phenotypes A, B, and C. The median age was 61.0 (51-69) years, 330 (67.6%) and 158 (32.4%) were men and women, respectively, 415 (85%) had pneumonia, and 161 (33%) had SpO<sub>2</sub> < 95% at admission. All-cause mortality occurred in 105 (21.5%) cases. It was higher in nonvaccinated versus vaccinated SOTR (23.4% vs 13.8%, P = 0.04). Patients in the entire cohort were classified into phenotypes A (n = 149, 30.5%), B (n = 187, 38.3%), and C (n = 152, 31.1%), with mortality rates of 8.7%, 16.6%, and 40.1%, respectively, which were similar to those of nonvaccinated SOTR (9.5%, 16.7%, and 52.0%) and lower in vaccinated SOTR (4.4%, 15.8%, and 17.3%, respectively), with difference between nonvaccinated and vaccinated in the phenotype C (P < 0.001). In conclusion, COVID-19 clinical phenotypes are useful in SOTR, and all-cause mortality decreases in vaccinated patients.</p>\",\"PeriodicalId\":21811,\"journal\":{\"name\":\"Scientific Reports\",\"volume\":\"14 1\",\"pages\":\"30021\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2024-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11612230/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scientific Reports\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.1038/s41598-024-81099-2\",\"RegionNum\":2,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scientific Reports","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1038/s41598-024-81099-2","RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study.
Clinical phenotypes of COVID-19, associated with mortality risk, have been identified in the general population. The present study assesses their applicability in solid organ transplant recipients (SOTR) hospital-admitted by COVID-19. In a cohort of 488 SOTR, nonvaccinated (n = 394) and vaccinated (n = 94) against SARS-CoV-2, we evaluated 16 demographic, clinical, analytical, and radiological variables to identify the clinical phenotypes A, B, and C. The median age was 61.0 (51-69) years, 330 (67.6%) and 158 (32.4%) were men and women, respectively, 415 (85%) had pneumonia, and 161 (33%) had SpO2 < 95% at admission. All-cause mortality occurred in 105 (21.5%) cases. It was higher in nonvaccinated versus vaccinated SOTR (23.4% vs 13.8%, P = 0.04). Patients in the entire cohort were classified into phenotypes A (n = 149, 30.5%), B (n = 187, 38.3%), and C (n = 152, 31.1%), with mortality rates of 8.7%, 16.6%, and 40.1%, respectively, which were similar to those of nonvaccinated SOTR (9.5%, 16.7%, and 52.0%) and lower in vaccinated SOTR (4.4%, 15.8%, and 17.3%, respectively), with difference between nonvaccinated and vaccinated in the phenotype C (P < 0.001). In conclusion, COVID-19 clinical phenotypes are useful in SOTR, and all-cause mortality decreases in vaccinated patients.
期刊介绍:
We publish original research from all areas of the natural sciences, psychology, medicine and engineering. You can learn more about what we publish by browsing our specific scientific subject areas below or explore Scientific Reports by browsing all articles and collections.
Scientific Reports has a 2-year impact factor: 4.380 (2021), and is the 6th most-cited journal in the world, with more than 540,000 citations in 2020 (Clarivate Analytics, 2021).
•Engineering
Engineering covers all aspects of engineering, technology, and applied science. It plays a crucial role in the development of technologies to address some of the world''s biggest challenges, helping to save lives and improve the way we live.
•Physical sciences
Physical sciences are those academic disciplines that aim to uncover the underlying laws of nature — often written in the language of mathematics. It is a collective term for areas of study including astronomy, chemistry, materials science and physics.
•Earth and environmental sciences
Earth and environmental sciences cover all aspects of Earth and planetary science and broadly encompass solid Earth processes, surface and atmospheric dynamics, Earth system history, climate and climate change, marine and freshwater systems, and ecology. It also considers the interactions between humans and these systems.
•Biological sciences
Biological sciences encompass all the divisions of natural sciences examining various aspects of vital processes. The concept includes anatomy, physiology, cell biology, biochemistry and biophysics, and covers all organisms from microorganisms, animals to plants.
•Health sciences
The health sciences study health, disease and healthcare. This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment of patients.